True North Advisors, LLC Dexcom Inc Transaction History

True North Advisors, LLC

  • $378 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

May 20, 2022
SELL
$95.51 - $112.95 $191,020 - $225,900
-2,000 Closed
0 $0
Q2 2020

May 20, 2022
SELL
$62.68 - $105.34 $1,316 - $2,212
-21 Reduced 1.04%
2,000 $810,000
Q1 2020

May 12, 2022
BUY
$47.79 - $75.63 $96,583 - $152,848
2,021 New
2,021 $544,000

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track True North Advisors, LLC Portfolio

Follow True North Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True North Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email